Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Tesla ended lowered salaries on June 29, CNBC reports » 18:52
07/02/20
07/02
18:52
07/02/20
18:52
TSLA

Tesla

$1,208.00 /

+88.84 (+7.94%)

Tesla told staff that it…

Tesla told staff that it ended a season of reduced pay for its salaried employees on June 29, 2020, as anticipated, CNBC's Lora Kolodny reports, citing internal correspondence. In mid-April, the car maker reduced pay for salaried workers by 10%-30% depending on their role, Kolodny says. At the time, the company cited coronavirus pressures on the business as a justification for the pay cuts, and said they expected the cuts to last until some time around Q2 of 2020, the author notes. In a new HR email, the car maker reiterated details about an upcoming performance review process, the author notes. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

  • 14
    Feb
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

Periodicals
Tesla says reports of workers let go over health concerns untrue, Bloomberg says » 18:41
07/02/20
07/02
18:41
07/02/20
18:41
TSLA

Tesla

$1,208.00 /

+88.84 (+7.94%)

The car maker said that…

The car maker said that it has waived its attendance policy for several weeks, and that it provides 14-day COVID-19 sick leave pay, Bloomberg reports. The company also said that the vast majority of its workers approve of the company's safety measures, according to Bloomberg.

ShowHide Related Items >><<
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

  • 14
    Feb
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

Hot Stocks
Zynga to acquire Toon Blast developer Peak for $1.85B » 16:57
07/02/20
07/02
16:57
07/02/20
16:57
ZNGA

Zynga

$9.52 /

-0.24 (-2.46%)

Zynga has entered into a…

Zynga has entered into a definitive agreement to acquire Peak, "one of the most globally successful mobile gaming companies, for $1.8B. Peak brings a 100-person strong team and two Forever Franchises, Toon Blast and Toy Blast, that have consistently ranked in the top 10 and top 20 U.S. iPhone grossing games for over two years, respectively. These franchises add significant scale to Zynga's live services and will be an additional driver of margin expansion over the coming years. Peak also enhances Zynga's new game pipeline with additional projects in early development." Founded in 2010 by Sidar Sahin, Peak has developed the beloved game franchises Toon Blast and Toy Blast. Known for their innovation, creativity and exquisite design, Toon Blast and Toy Blast popularized the 'collapse' mechanic within match-3 puzzle games, and have captured a highly engaged global audience base that ranks among the industry's best in player retention. Collectively, Toon Blast and Toy Blast have more than 12 million average mobile DAUs. Peak is expected to grow Zynga's average mobile DAUs by more than 60% while strengthening Zynga's international audience," said the company in a statement earlier. Reference Link

ShowHide Related Items >><<
ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

06/22/20 MKM Partners
Snap's new features impressive, says MKM Partners
06/09/20
Fly Intel: Top five analyst upgrades
06/09/20 Barclays
Barclays upgrades Zynga with Peak seen as share inflection point
06/09/20 Barclays
Zynga upgraded to Overweight from Equal Weight at Barclays
ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

On The Fly
Fly Intel: Wall Street's top stories for Thursday » 16:32
07/02/20
07/02
16:32
07/02/20
16:32
TSLA

Tesla

$1,208.00 /

+88.84 (+7.94%)

, F

Ford

$6.05 /

+0.065 (+1.09%)

, MCD

McDonald's

$183.55 /

-0.95 (-0.51%)

, LMND

Lemonade

$69.38 /

+ (+0.00%)

, MRNA

Moderna

$58.57 /

-3.06 (-4.97%)

, GRAF

Graf Industrial

$20.56 /

+6.605 (+47.33%)

, NUS

Nu Skin

$48.09 /

+9.605 (+24.96%)

, MEIP

MEI Pharma

$3.48 /

-0.79 (-18.50%)

, MTCH

Match Group

$98.89 /

-7.35 (-6.92%)

Stocks closed out the…

Open Full Text

ShowHide Related Items >><<
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

NUS Nu Skin
$48.09 /

+9.605 (+24.96%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

GRAF Graf Industrial
$20.56 /

+6.605 (+47.33%)

F Ford
$6.05 /

+0.065 (+1.09%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
F Ford
$6.05 /

+0.065 (+1.09%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
Ford price target raised to $7 from $6 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
MCD McDonald's
$183.55 /

-0.95 (-0.51%)

06/24/20 BMO Capital
McDonald's price target raised to $220 from $215 at BMO Capital
06/24/20 JPMorgan
McDonald's price target raised to $204 from $180 at JPMorgan
06/17/20 Morgan Stanley
McDonald's price target raised to $200 from $189 at Morgan Stanley
06/17/20 SunTrust
McDonald's price target raised to $208 from $195 at SunTrust
LMND Lemonade
$69.38 /

+ (+0.00%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/26/20 Morgan Stanley
Morgan Stanley says Axios overstates contention on Moderna-NIH vaccine ownership
GRAF Graf Industrial
$20.56 /

+6.605 (+47.33%)

NUS Nu Skin
$48.09 /

+9.605 (+24.96%)

07/02/20
Fly Intel: Top five analyst upgrades
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07/02/20 Jefferies
Jefferies upgrades Nu Skin to Buy, sees 15%-20% share upside
MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

05/29/20
Fly Intel: Top five analyst initiations
05/29/20 SunTrust
MEI Pharma initiated with a Buy at SunTrust
04/14/20 JonesTrading
MEI Pharma price target raised to $9 from $6 at JonesTrading
04/14/20 Wells Fargo
MEI Pharma price target raised to $13 from $11 at Wells Fargo
MTCH Match Group
$98.89 /

-7.35 (-6.92%)

07/02/20 BTIG
IAC price target lowered to $150 from $330 at BTIG
06/23/20 SunTrust
SunTrust raises price targets on IAC, Angi Homeservices, Match Group
06/23/20 BMO Capital
Angi Homeservices price target raised to $16 from $10 at BMO Capital
06/23/20 BMO Capital
IAC price target raised to $369 from $316 at BMO Capital
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

NUS Nu Skin
$48.09 /

+9.605 (+24.96%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

F Ford
$6.05 /

+0.065 (+1.09%)

  • 02
    Jul
  • 19
    May
  • 14
    Feb
  • 12
    Feb
  • 17
    Dec
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

GRAF Graf Industrial
$20.56 /

+6.605 (+47.33%)

F Ford
$6.05 /

+0.065 (+1.09%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

F Ford
$6.05 /

+0.065 (+1.09%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

F Ford
$6.05 /

+0.065 (+1.09%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

Hot Stocks
ViiV Healthcare announces FDA approval of Rukobia for HIV » 16:19
07/02/20
07/02
16:19
07/02/20
16:19
GSK

GlaxoSmithKline

$41.22 /

+0.35 (+0.86%)

, PFE

Pfizer

$34.52 /

+0.78 (+2.31%)

ViiV Healthcare, the…

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline (GSK), with Pfizer (PFE) and Shionogi Limited as shareholders, announced that the U.S. Food and Drug Administration has approved Rukobia 600 mg extended-release tablets. Rukobia is a novel attachment inhibitor for the treatment of HIV-1 infection indicated for use in combination with other antiretroviral therapies in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection, who are failing their current ARV regimen due to resistance, intolerance or safety considerations. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$34.52 /

+0.78 (+2.31%)

GSK GlaxoSmithKline
$41.22 /

+0.35 (+0.86%)

GSK GlaxoSmithKline
$41.22 /

+0.35 (+0.86%)

06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
PFE Pfizer
$34.52 /

+0.78 (+2.31%)

07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
07/02/20 SVB Leerink
BioNTech price target raised to $42 from $37 at SVB Leerink
07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
PFE Pfizer
$34.52 /

+0.78 (+2.31%)

GSK GlaxoSmithKline
$41.22 /

+0.35 (+0.86%)

PFE Pfizer
$34.52 /

+0.78 (+2.31%)

GSK GlaxoSmithKline
$41.22 /

+0.35 (+0.86%)

PFE Pfizer
$34.52 /

+0.78 (+2.31%)

GSK GlaxoSmithKline
$41.22 /

+0.35 (+0.86%)

PFE Pfizer
$34.52 /

+0.78 (+2.31%)

GSK GlaxoSmithKline
$41.22 /

+0.35 (+0.86%)

Hot Stocks
Tesla's Musk issues series of tweets appearing to taunt SEC, short-sellers » 15:07
07/02/20
07/02
15:07
07/02/20
15:07
TSLA

Tesla

$1,214.00 /

+94.84 (+8.47%)

In a series of tweets,…

In a series of tweets, Tesla CEO Elon Musk stated: "Who wears short shorts? ... Tesla will make fabulous short shorts in radiant red satin with gold trim ... Will send some to the Shortseller Enrichment Commission to comfort them through these difficult times ... SEC, three letter acronym, middle word is Elon's" Reference Link

ShowHide Related Items >><<
TSLA Tesla
$1,214.00 /

+94.84 (+8.47%)

TSLA Tesla
$1,214.00 /

+94.84 (+8.47%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
TSLA Tesla
$1,214.00 /

+94.84 (+8.47%)

  • 14
    Feb
TSLA Tesla
$1,214.00 /

+94.84 (+8.47%)

TSLA Tesla
$1,214.00 /

+94.84 (+8.47%)

TSLA Tesla
$1,214.00 /

+94.84 (+8.47%)

TSLA Tesla
$1,214.00 /

+94.84 (+8.47%)

Periodicals
Tesla wants go-ahead for Giga-Berlin prior to final approval, Electrek says » 14:34
07/02/20
07/02
14:34
07/02/20
14:34
TSLA

Tesla

$1,204.50 /

+85.34 (+7.63%)

Gigafactory Berlin, a key…

Gigafactory Berlin, a key component in Tesla's European growth plan, is scheduled to go online in July 2021, Electrek's Fred Lambert wrote on Wednesday afternoon, citing Germany's Postdamer. According to Electrek, Tesla "wants to slash costs by producing vehicles locally and avoid the expense of shipping vehicles from California to the old continent." According to the Electrek story, translating from a German publication: "The Brandenburg Ministry of the Environment confirmed on Monday that Tesla, along with amended documents on the previous application for approval under the Federal Immission Control Act for the factory, had 'submitted another application for approval of the early start of measures... 'for parts of a building shell." Reference Link

ShowHide Related Items >><<
TSLA Tesla
$1,204.50 /

+85.34 (+7.63%)

TSLA Tesla
$1,204.50 /

+85.34 (+7.63%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
TSLA Tesla
$1,204.50 /

+85.34 (+7.63%)

  • 14
    Feb
TSLA Tesla
$1,204.50 /

+85.34 (+7.63%)

TSLA Tesla
$1,204.50 /

+85.34 (+7.63%)

TSLA Tesla
$1,204.50 /

+85.34 (+7.63%)

TSLA Tesla
$1,204.50 /

+85.34 (+7.63%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 13:00
07/02/20
07/02
13:00
07/02/20
13:00
TSLA

Tesla

$1,213.83 /

+94.67 (+8.46%)

, F

Ford

$6.09 /

+0.11 (+1.84%)

, MCD

McDonald's

$184.61 /

+0.11 (+0.06%)

, LMND

Lemonade

$61.18 /

+ (+0.00%)

, BLFS

BioLife Solutions

$17.80 /

+1.71 (+10.63%)

, NUS

Nu Skin

$47.52 /

+9.04 (+23.49%)

, MEIP

MEI Pharma

$3.53 /

-0.745 (-17.45%)

, NLTX

Neoleukin Therapeutics

$14.40 /

-2.66 (-15.59%)

Stocks are up about 1%…

Open Full Text

ShowHide Related Items >><<
TSLA Tesla
$1,213.83 /

+94.67 (+8.46%)

NUS Nu Skin
$47.52 /

+9.04 (+23.49%)

NLTX Neoleukin Therapeutics
$14.40 /

-2.66 (-15.59%)

MEIP MEI Pharma
$3.53 /

-0.745 (-17.45%)

MCD McDonald's
$184.61 /

+0.11 (+0.06%)

F Ford
$6.09 /

+0.11 (+1.84%)

BLFS BioLife Solutions
$17.80 /

+1.71 (+10.63%)

TSLA Tesla
$1,213.83 /

+94.67 (+8.46%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
F Ford
$6.09 /

+0.11 (+1.84%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
Ford price target raised to $7 from $6 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
MCD McDonald's
$184.61 /

+0.11 (+0.06%)

06/24/20 BMO Capital
McDonald's price target raised to $220 from $215 at BMO Capital
06/24/20 JPMorgan
McDonald's price target raised to $204 from $180 at JPMorgan
06/17/20 Morgan Stanley
McDonald's price target raised to $200 from $189 at Morgan Stanley
06/17/20 SunTrust
McDonald's price target raised to $208 from $195 at SunTrust
LMND Lemonade
$61.18 /

+ (+0.00%)

BLFS BioLife Solutions
$17.80 /

+1.71 (+10.63%)

07/02/20 Lake Street
BioLife Solutions supplementing cash position 'makes sense,' says Lake Street
05/15/20 Stephens
BioLife Solutions price target raised to $24 after 'strong' Q1 beat at Stephens
03/23/20 H.C. Wainwright
BioLife Solutions price target lowered to $17 from $26 at H.C. Wainwright
02/24/20 Lake Street
BioLife Solutions initiated with a Buy at Lake Street
NUS Nu Skin
$47.52 /

+9.04 (+23.49%)

07/02/20
Fly Intel: Top five analyst upgrades
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07/02/20 Jefferies
Jefferies upgrades Nu Skin to Buy, sees 15%-20% share upside
MEIP MEI Pharma
$3.53 /

-0.745 (-17.45%)

05/29/20
Fly Intel: Top five analyst initiations
05/29/20 SunTrust
MEI Pharma initiated with a Buy at SunTrust
04/14/20 JonesTrading
MEI Pharma price target raised to $9 from $6 at JonesTrading
04/14/20 Wells Fargo
MEI Pharma price target raised to $13 from $11 at Wells Fargo
NLTX Neoleukin Therapeutics
$14.40 /

-2.66 (-15.59%)

06/24/20 Piper Sandler
Neoleukin Therapeutics price target raised to $28 from $20 at Piper Sandler
06/23/20 Guggenheim
Neoleukin's preclinical data for NL-201 'checks all the boxes,' says Guggenheim
06/22/20 Piper Sandler
Neoleukin presentations support 'best-in-class approach,' says Piper Sandler
06/18/20
Fly Intel: Top five analyst initiations
TSLA Tesla
$1,213.83 /

+94.67 (+8.46%)

NUS Nu Skin
$47.52 /

+9.04 (+23.49%)

NLTX Neoleukin Therapeutics
$14.40 /

-2.66 (-15.59%)

MEIP MEI Pharma
$3.53 /

-0.745 (-17.45%)

MCD McDonald's
$184.61 /

+0.11 (+0.06%)

F Ford
$6.09 /

+0.11 (+1.84%)

BLFS BioLife Solutions
$17.80 /

+1.71 (+10.63%)

  • 02
    Jul
  • 02
    Jul
  • 02
    Jul
  • 14
    Feb
  • 18
    Dec
  • 17
    Dec
TSLA Tesla
$1,213.83 /

+94.67 (+8.46%)

MCD McDonald's
$184.61 /

+0.11 (+0.06%)

F Ford
$6.09 /

+0.11 (+1.84%)

TSLA Tesla
$1,213.83 /

+94.67 (+8.46%)

NUS Nu Skin
$47.52 /

+9.04 (+23.49%)

NLTX Neoleukin Therapeutics
$14.40 /

-2.66 (-15.59%)

MEIP MEI Pharma
$3.53 /

-0.745 (-17.45%)

MCD McDonald's
$184.61 /

+0.11 (+0.06%)

F Ford
$6.09 /

+0.11 (+1.84%)

BLFS BioLife Solutions
$17.80 /

+1.71 (+10.63%)

TSLA Tesla
$1,213.83 /

+94.67 (+8.46%)

MEIP MEI Pharma
$3.53 /

-0.745 (-17.45%)

MCD McDonald's
$184.61 /

+0.11 (+0.06%)

F Ford
$6.09 /

+0.11 (+1.84%)

TSLA Tesla
$1,213.83 /

+94.67 (+8.46%)

On The Fly
Livongo Health downgrade, Avis upgrade among today's top calls on Wall Street » 10:02
07/02/20
07/02
10:02
07/02/20
10:02
LVGO

Livongo Health

$75.02 /

+0.61 (+0.82%)

, CAR

Avis Budget

$27.17 /

+4.7 (+20.92%)

, TSLA

Tesla

$1,209.48 /

+90.32 (+8.07%)

, HIBB

Hibbett Sports

$23.15 /

+2.37 (+11.41%)

, NUS

Nu Skin

$46.39 /

+7.91 (+20.56%)

Check out today's top…

Open Full Text

ShowHide Related Items >><<
TSLA Tesla
$1,209.48 /

+90.32 (+8.07%)

NUS Nu Skin
$46.39 /

+7.91 (+20.56%)

LVGO Livongo Health
$75.02 /

+0.61 (+0.82%)

HIBB Hibbett Sports
$23.15 /

+2.37 (+11.41%)

CAR Avis Budget
$27.17 /

+4.7 (+20.92%)

LVGO Livongo Health
$75.02 /

+0.61 (+0.82%)

07/02/20 Goldman Sachs
Livongo Health downgraded to Neutral from Buy at Goldman Sachs
06/30/20 Piper Sandler
Virtual care market to benefit from PHE extension, says Piper Sandler
06/25/20 Cowen
Livongo Health price target raised to $88 from $69 at Cowen
06/22/20 KeyBanc
KeyBanc boosts Livongo target to $85, says yes, you can keep buying
CAR Avis Budget
$27.17 /

+4.7 (+20.92%)

07/02/20 Morgan Stanley
Morgan Stanley upgrades Avis to Overweight after raising used car price forecast
07/02/20 Morgan Stanley
Avis Budget upgraded to Overweight from Equal Weight at Morgan Stanley
06/24/20 Jefferies
CarMax, AutoNation could be eyeing Hertz in bankruptcy, says Jefferies
06/19/20 JPMorgan
Avis Budget price target raised to $22 from $13 at JPMorgan
TSLA Tesla
$1,209.48 /

+90.32 (+8.07%)

07/02/20 Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
HIBB Hibbett Sports
$23.15 /

+2.37 (+11.41%)

07/02/20 BofA
BofA double upgrades Hibbett Sports on COVID market share gains
07/02/20 BofA
Hibbett Sports upgraded to Buy from Underperform at BofA
05/27/20
Fly Intel: Top five analyst upgrades
05/27/20 Susquehanna
Hibbett Sports upgraded to Positive at Susquehanna
NUS Nu Skin
$46.39 /

+7.91 (+20.56%)

07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07/02/20 Jefferies
Jefferies upgrades Nu Skin to Buy, sees 15%-20% share upside
07/02/20 Jefferies
Nu Skin upgraded to Buy from Hold at Jefferies
TSLA Tesla
$1,209.48 /

+90.32 (+8.07%)

NUS Nu Skin
$46.39 /

+7.91 (+20.56%)

LVGO Livongo Health
$75.02 /

+0.61 (+0.82%)

HIBB Hibbett Sports
$23.15 /

+2.37 (+11.41%)

CAR Avis Budget
$27.17 /

+4.7 (+20.92%)

  • 14
    Feb
  • 12
    Dec
  • 25
    Jul
TSLA Tesla
$1,209.48 /

+90.32 (+8.07%)

LVGO Livongo Health
$75.02 /

+0.61 (+0.82%)

HIBB Hibbett Sports
$23.15 /

+2.37 (+11.41%)

CAR Avis Budget
$27.17 /

+4.7 (+20.92%)

TSLA Tesla
$1,209.48 /

+90.32 (+8.07%)

NUS Nu Skin
$46.39 /

+7.91 (+20.56%)

LVGO Livongo Health
$75.02 /

+0.61 (+0.82%)

HIBB Hibbett Sports
$23.15 /

+2.37 (+11.41%)

CAR Avis Budget
$27.17 /

+4.7 (+20.92%)

TSLA Tesla
$1,209.48 /

+90.32 (+8.07%)

LVGO Livongo Health
$75.02 /

+0.61 (+0.82%)

CAR Avis Budget
$27.17 /

+4.7 (+20.92%)

TSLA Tesla
$1,209.48 /

+90.32 (+8.07%)

Recommendations
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR » 09:59
07/02/20
07/02
09:59
07/02/20
09:59
NVAX

Novavax

$79.15 /

-0.55 (-0.69%)

, PFE

Pfizer

$34.29 /

+0.55 (+1.63%)

, BNTX

BioNTech

$68.28 /

+4.19 (+6.54%)

B. Riley FBR analyst…

B. Riley FBR analyst Mayank Mamtani tells investors to take advantage of the pullback in Novavax (NVAX) shares after Pfizer (PFE) and BioNTech (BNTX) released preliminary Phase I/II safety and immunogenicity dataset for its mRNA-based COVID-19 vaccine candidate. The analyst is encouraged by the "first-of-its-kind detailed update" for a clinical stage COVID-19 vaccine and does not believe the data confer negative read-through to alternative platform approaches. Safety and dose-dependent effect could emerge as key differentiating factors for Novavax, Mamtani tells investors in a research note. The analyst keeps a Buy rating on Novavax with a $106 price target.

ShowHide Related Items >><<
PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
06/29/20 H.C. Wainwright
Novavax price target raised to $101 from $50 at H.C. Wainwright
06/19/20 Cantor Fitzgerald
Novavax price target raised to $88 from $45 at Cantor Fitzgerald
06/05/20
Fly Intel: Top five analyst upgrades
PFE Pfizer
$34.29 /

+0.55 (+1.63%)

07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
07/02/20 SVB Leerink
BioNTech price target raised to $42 from $37 at SVB Leerink
07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
BNTX BioNTech
$68.28 /

+4.19 (+6.54%)

07/02/20 Bryan Garnier
BioNTech price target raised to $62.50 from $50 at Bryan Garnier
PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

BNTX BioNTech
$68.28 /

+4.19 (+6.54%)

  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

BNTX BioNTech
$68.28 /

+4.19 (+6.54%)

PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

BNTX BioNTech
$68.28 /

+4.19 (+6.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.